An asset purchase agreement has been signed with Dexcel Pharma USA, which will acquire the full rights to Zubsolv® in the US, at a purchase price of USD 91 million plus the value of inventory at closi ...
The Goldman Sachs Group, Inc. (NYSE:GS) is one of the stocks that was on Jim Cramer’s radar. Cramer highlighted the company’s ...
On results, Vinci generated fee-related earnings of R$53.8 million or R$1.02 per share and adjusted distributable earnings of R$57.1 million or R$1.08 per share for the third quarter 2024. Alessandro ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback